Related Experiment Video
Updated: Aug 18, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Myxobacterial epothilones and tubulysins as promising anticancer agents
Alexander Dömling1, Wolfgang Richter
1R&D Biopharmaceuticals, München, Germany. alexander.doemling@t-online.de
Molecular Diversity
|March 26, 2005
Abstract:
Tubulin-binding agents play a pivotal role in current cancer therapy and there are many efforts in pre-clinical and clinical development of known and novel cytotoxic agents ongoing. In this article a known class, epothilones, as well as a novel class, tubulysins, are presented.
Insights
Tubulin-binding agents are crucial for cancer therapy. This article reviews established epothilones and novel tubulysins, highlighting their roles in ongoing pre-clinical and clinical cytotoxic agent development.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Tubulin-binding agents are essential in cancer treatment.
- Ongoing research focuses on developing novel cytotoxic agents.
- Epothilones and tubulysins represent key classes of these agents.
Purpose of the Study:
- To present epothilones, a known class of tubulin-binding agents.
- To introduce tubulysins, a novel class of tubulin-binding agents.
- To discuss their relevance in current cancer therapy research.
Main Methods:
- Literature review of epothilones.
- Review of pre-clinical and clinical data on tubulysins.
- Comparative analysis of cytotoxic agent development.
Main Results:
- Epothilones are established tubulin-binding agents with therapeutic applications.
- Tubulysins demonstrate potential as novel cytotoxic agents.
- Both classes contribute to advancements in cancer treatment strategies.
Conclusions:
- Tubulin-binding agents, including epothilones and tubulysins, are vital in oncology.
- Continued research into these agents promises new therapeutic options for cancer patients.
- The development of novel agents like tubulysins is critical for improving cancer therapy outcomes.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...